From: The role of polyphenols in overcoming cancer drug resistance: a comprehensive review
Compound | Chemotherapeutic drug | Result | Refs. |
---|---|---|---|
Curcumin | Gefitinib | Enhances the efficacy of the drug and overcomes the EGFR-TKI resistance in NSCLC patients with wild-type EGFR and/or KRAS mutation | [150] |
5-Fluorouracil | Exerts synergistic effect with the chemotherapeutic drug by impairing AMPK/ULK1-dependent autophagy | [155] | |
Docetaxel | Leads to induction of apoptosis and autophagy through PI3K/AKT/mTOR pathway | [156] | |
Resveratrol | Cisplatin | Induces autophagic and apoptotic death in drug-resistant oral cancer cells | [151] |
Gefitinib | Overcomes drug resistance while inducing apoptosis, autophagy, and senescence in PC9/G NSCLC cells | [157] | |
EGCG | Cisplatin | Increases sensitivity of CAR cells, apoptosis, and autophagy by AKT/STAT3 pathway | [154] |
Apigenin | Cisplatin | Inhibits growth of drug-resistant colon cancer cells while inducing autophagy | [158] |
Liquiritin | Cisplatin | Induces apoptosis and autophagy in drug-resistant gastric cancer cells | [159] |
GL-V9 | Adriamycin | Reverses drug resistance by blocking JNK2-related protective autophagy in HCC | [160] |